Ransomware victim disclosure
← All victimsCristália - Indústria Farmacêutica
Claimed by Atomsilo · listed 4 years ago
Status timeline
- Listed
Dec 21, 2021
- Data leaked
At a glance
- Group
- Atomsilo
- Status
- Data leaked
- Country
- Brazil
- Sector
- Healthcare
- Listed on leak site
- Dec 21, 2021
About the victim
AI dossier — public-source company profileCristália - Indústria Farmacêutica is a 100% Brazilian pharmaceutical, pharmochemical, and biotechnology industrial complex founded in 1972. It produces approximately 350 medicines in over 500 pharmaceutical presentations across hospital, pharma, and ophthalmic lines, and is the largest producer of anesthetics in Latin America. The company holds 131 patents and is the only Brazilian laboratory capable of developing all stages of a new medicine's production, from molecule conception to final product.
- Industry
- Pharmaceutical Manufacturing & Biotechnology
- Employees
- 1001-5000
- Founded
- 1972
Attack summary
Severity: critical — Confirmed data publication by a ransomware group against a major pharmaceutical manufacturer handling sensitive R&D, proprietary drug formulations, patents, and potentially patient/clinical data at scale in a critical healthcare sector.The Atomsilo ransomware group claims an attack on Cristália - Indústria Farmacêutica with data published, indicating confirmed exfiltration. The specific data types and volume exfiltrated have not been detailed in the leak post.
Data the group says was taken
AI dossier — extracted from the leak post- Pharmaceutical research and development data
- Patent documentation
- Hospital and clinical product records
- Active pharmaceutical ingredient formulations
- Business operational data
Original description
AI-summarised, not from the leak postCristália - Indústria Farmacêutica is a premier pharmaceutical company based in Brazil. Founded in 1972, it is renowned for contributing to major advancements in the medical and pharmaceutical field. The company produces medicines, hospital products, and active pharmaceutical ingredients. Cristália stands out in the industry with over 200 patents and specializes in various therapeutic classes, including psychiatry, anesthesia, and oncology.
Sources
Source
Indexed 4 years agoThis page surfaces a public ransomware disclosure indexed by Darkfield. Original posts come from the operator's own leak site; we cross-check against ransomware.live, RansomLook and RansomWatch where applicable. Share this URL freely.
